We have put together a list of top-licensed technologies by our Life Sciences team. Please connect with the corresponding business development officers for each technology via email below;
Tariq Arif Ragan Robertson Mark Wisniewski Earl Weinstein
FEATURED BIOSCIENCE TECHNOLOGIES
| Officer | Technologies | Links to Portfolios |
|
Arif, Tariq |
2017-431 XENOBIOTIC-FREE CULTURE SYSTEM TO EXPAND HUMAN LIMBAL STEM CELLS | http://ucla.technologypublisher.com/techcase/18-1282 | |||||
| 2019-336 CARBORANE-BASED HISTONE DEACETYLASE (HDAC) INHIBITORS | http://ucla.technologypublisher.com/technology/36129 | ||||||
| 2020-408 SAPPALPHA TAREGETED THERAPEUTICS FOR ALZHEIMER’S DISEASE | http://ucla.technologypublisher.com/technology/41968 | ||||||
| 2020-871 SAFE POTENT SINGLE VECTOR PLATFORM VACCINE AGAINST COVID-19 | http://ucla.technologypublisher.com/techcase/20-0382 | ||||||
| 2019-341 MICROBIOME-BASED REGULATION OF COGNITIVE BEHAVIOR | http://ucla.technologypublisher.com/techcase/20-0383 | ||||||
| 2020-120 NOVEL MOUSE MODELS FOR GENETICALLY-DIRECTED SPARSE AND COMPLETE LABELING OF BRAIN CELLS FOR ANALYSIS OF BRAIN CELL BIOLOGY AND PATHOLOGY | http://ucla.technologypublisher.com/technology/41347 | ||||||
| 2020-777 CORRECTING NEURONAL DYSFUNCTION IN INTELLECTUAL DISABILITY SYNDROMES | http://ucla.technologypublisher.com/technology/41224 | ||||||
| 2020-916 STRUCTURE-BASED DESIGN OF ANTISENSE OLIGONUCLEOTIDE DRUGS | http://ucla.technologypublisher.com/techcase/20-0332 | ||||||
| 2019-336 CARBORANE-BASED HISTONE DEACETYLASE (HDAC) INHIBITORS | http://ucla.technologypublisher.com/technology/36129 | ||||||
| 2019-880 ZIKA VIRUS-BASED ONCOLYTIC THERAPY FOR BRAIN CANCER | http://ucla.technologypublisher.com/technology/40482 | ||||||
| 2016-750 2019-355 Melissa Spenser Deck |
|
||||||
| 2018-717 2020-916 Feng Guo (DMD) |
http://ucla.technologypublisher.com/technology/39561 | ||||||
| 2019-720 2020-777 Bill Lowry |
http://ucla.technologypublisher.com/technology/41224 | ||||||
For any technologies on the above list, contact, Tariq Arif - tariq.arif@tdg.ucla.edu
| Officer | Technologies | Links to Portfolios |
| Robertson, Ragan | 2016-518 Inhibition of Protein Tyrosine Phosphatase-Sigma for Hematopoietic Regeneration | http://ucla.technologypublisher.com/technology/35946 | ||
| 2016-529 Inhibitors of IRES-Mediated Protein Synthesis | http://ucla.technologypublisher.com/technology/35947 | |||
| 2017-460 Optimized Lentiviral Vector (CCLC-MGATA/ANK-CORELCR-BAS3-FB) for Stem Cell Gene Therapy of Hemoglobinopathies | http://ucla.technologypublisher.com/technology/35031 | |||
| 2016-290 TRANSIENT EXPRESSION OF BCL-2 TO AMELIORATE CYTOTOXICITY OF GENE MODIFICATION REAGENTS IN STEM CELLS. | http://ucla.technologypublisher.com/technology/35717 | |||
| 2018-370 NOVEL TUMOR INHIBITORS FOR THE TREATMENT OF CANCER | http://ucla.technologypublisher.com/techcase/19-0032 | |||
| 2018-372 DEVELOPMENT OF METHODS TO EFFECTIVELY EDIT GENES IN HEMATOPOIETIC STEM CELLS TO CORRECT GENETIC DISEASES | http://ucla.technologypublisher.com/technology/28442 | |||
| 2018-175 Targeted Inhibition of Human Multiple Myeloma | http://ucla.technologypublisher.com/technology/28444 | |||
| 2019-281 PLOD3-TARGETED ANTI-CANCER TREATMENT | ||||
| 2018-714 NOVEL SMALL MOLECULE DRUG TO TREAT DIABETIC KIDNEY DISEASE | ||||
| 2018-862 GENERATION OF MINIMAL ENHANCER ELEMENTS USING MASSIVELY PARALLEL REPORTER ASSAYS | http://ucla.technologypublisher.com/technology/35044 | |||
| 2019-479 IDENTIFICATION OF PAN-CANCER SMALL CELL NEUROENDOCRINE PHENOTYPES AND VULNERABILITIES | http://ucla.technologypublisher.com/technology/35854 | |||
| 2015-450 IMPROVEMENT TO RETROVIRAL VECTORS CONTAINING THE HUMAN UBIQUITIN C PROMOTER | http://ucla.technologypublisher.com/technology/35702 | |||
| 2019-314 BIOMIMETIC CONDUCTIVE HYDROGELS | http://ucla.technology.publisher.com/technology/35863 | |||
|
|
For more on the above technologies contact, Ragan Robertson - ragan.robertson@tdg.ucla.edu
| Officer | Technologies | Links to Portfolios |
| Rosenthal, Guy | 2015-613 A Novel Method for Generating Human Dendritic Cells for Immunotherapy | http://ucla.technologypublisher.com/technology/35931 |
| 2015-348 Combination Immunotherapy | http://ucla.technologypublisher.com/technology/35703 | |
| 2010-243 Application of Topical Resveratrol in the Treatment of Acne | http://ucla.technologypublisher.com/technology/35952 | |
| 2018-369 BIOMIMETIC ARTIFICIAL PERIODONTAL MEMBRANES AND METHOD OF FABRICATING THE SAME | http://ucla.technologypublisher.com/technology/35822 | |
| 2018-680 SINGLE-CHAIN BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING BCMA AND CS1 FOR THE TREATMENT OF MULTIPLE MYELOMA | http://ucla.technologypublisher.com/technology/35870 | |
| 2018-720 CREATINE FOR IMMUNOTHERAPY | http://ucla.technologypublisher.com/technology/37147 | |
| 2019-008 COMPOSITION OF NY-ESO-1-SPECIFIC T CELL RECEPTORS RESTRICTED ON MULTIPLE MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES | http://ucla.technologypublisher.com/technology/35839 | |
| 2018-470 NOVEL SOURCES OF HEMATOPOIETIC PROGENITOR CELLS | http://ucla.technologypublisher.com/technology/36119 | |
| 2018-860 METHODS OF GENERATING NON-ALLOREACTIVE T-CELLS FROM PROGENITOR CELLS AND IMMUNOTHERAPEUTIC METHODS USING THE T-CELLS | ||
| 2019-027 SMALL MOLECULE DRUGS ACCELERATE IMPLANT OSSEOINTEGRATION | http://ucla.technologypublisher.com/technology/36872 | |
| 2019-706 USE OF DUPILUMAB FOR DISSEMINATED FUNGAL INFECTION | ||
| 2019-693 IDENTIFICATION OF A PLATFORM FOR T CELL RECEPTOR RECOGNITION OF SPLICE VARIATION NEOANTIGENS IN GLIOBLASTOMA | http://ucla.technologypublisher.com/technology/40125 | |
| 2019-694 ROLE OF BACTERIAL RNA IN INFLAMMATION IN ACNE | http://ucla.technologypublisher.com/technology/36335 | |
| 2019-876 MAINTAINING FUNCTIONS AND PHENOTYPES OF CONNECTIVE TISSUE THROUGH NPAS2 SUPPRESSION | http://ucla.technologypublisher.com/technology/37428 | |
| 2020-193 3D SCAFFOLD FOR T CELL DELIVERY AND SUPPRESSION OF TREGS FOR SOLID TUMORS | http://ucla.technologypublisher.com/technology/37511 | |
| 2020-884 METHOD TO SEQUENCE MRNA IN SINGLE CELLS IN PARALLEL WITH QUANTIFICATION OF INTRACELLULAR PHENOTYPE | http://ucla.technologypublisher.com/technology/40900 | |
| 2019-726 AUGMENTATING T-CELL ACTIVATION BY OSCILLATORY FORCES AND ENGINEERED ANTIGEN-PRESENTING CELLS | http://ucla.technologypublisher.com/technology/41225 | |
| 2020-840 BISPECIFIC AND MULTI-SPECIFIC CARS FOR THE TREATMENT OF IMMUNOSUPPRESSIVE GLIOBLASTOMA | http://ucla.technologypublisher.com/technology/41324 | |
| 2020-763 DENTAL WHITE SPOT TREATMENT | http://ucla.technologypublisher.com/technology/41300 | |
| 2021-008 TARGETED NEOANTIGEN VACCINATION IN H3G34R/V GLIOMA | http://ucla.technologypublisher.com/technology/41348 |
For more on the above technologies please contact, Mark Wisniewski - mark.wisniewski@tdg.ucla.edu
| Officer | Technologies | Link to Portfolio |
| Weinstein, Earl | 2018-022 SMALL MOLECULE MODULATORS THAT MEDIATE PINK1 AND PARKIN TRAFFICKING IN MITOCHONDRIA | http://ucla.technologypublisher.com/technology/37330 |
| 2018-437 SCALABLE LIPID BILAYER MICROFLUIDICS FOR HIGH-THROUGHPUT GENE EDITING | http://ucla.technologypublisher.com/technology/35866 | |
| 2014-111 IN VITRO RECONSTITUTED PLANT VIRUS CAPIDS FOR DELIVERING RNA GENES TO MAMMALIAN CELLS | http://ucla.technologypublisher.com/technology/35030 |
| 2019-603 HYDRODEALKENYLATIVE C(SP3)–C(SP2) BOND SCISSION | http://ucla.technologypublisher.com/technology/35051 | |
| 2019-958 SELECTIVE HDAC INHIBITORS | http://ucla.technologypublisher.com/technology/37383 | |
| 2019-833 SMALL MOLECULE HETEROCYCLIC GOAT INHIBITORS | http://ucla.technologypublisher.com/technology/37272 |
For more on the above technologies please contact, Earl Weinstein - eweinstein@tdg.ucla.edu